4[4]Mackness B, Harty D, Bhatnagar D, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin dependent diabetes mellitus. Atherosclerosis, 1991, 86:193-199
5[5]Gan KN, Smolen A, Eckerson HW, et al. Purification of human serum paraoxonase /arylesterase. Drug Metab dispos, 1991, 19:100-106
6[6]Navab M, Hama LS, Van LBJ, et al. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest, 1997, 99:2005-019
7[7]Aviram M, Rosenblat M, Bisgaier CL. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest, 1998, 101:1581-590
8[8]Leviev I, James RW. Promoter polymorphisms of htunan paraoxonase PON-1gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol, 2000, 20:516-521
9[9]AviramM, Hardak E, VayaJ, etal. Human serum paraoxonases(PON-1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON-1 esterase and peroxidase-like activities. Circulation,2000, 101:2 510-517
10[10]Xu XP, Meisel SR, Ong HM, et al. oxidized low-density liprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Ciriulation, 1999, 99:993-998
4WHO-ISH. Hypertension Guidelines Committee. 1999 World Health Or- ganization-International Society of Hypertension Guidelines for the man- agement of hypertension [ J ]. J Hypertens, 1999 ; 17 : 151-83.
5Failla M, Giannattasio C, Piperno A, et al. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy [J]. Hepatology, 2000 ; 32 : 569 -73.
